PRELUDE THERAPEUTICS INC Revenue Breakdown
No Revenue Breakdown for PRLD on this site yet.
- 2025-12-31: Others Not split by product in the filing$12.14M100.00%; Total revenue $12.14M.
- 2024-12-31: Others Not split by product in the filing$7.00M100.00%; Total revenue $7.00M.
Source checked: the stored Revenue Breakdown page for PRLD.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $12.14M 100.00% | $12.14M |
| 2024-12-31 | Not split by product in the filing $7.00M 100.00% | $7.00M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $5.70M 100.00% | $5.70M |
| 2026-03-31 | Not split by product $4.58M 100.00% | $4.58M |
| 2025-12-31 | Not split by product $5.64M 100.00% | $5.64M |
| 2025-09-30 | Not split by product $6.50M 100.00% | $6.50M |
| 2025-06-30 | Not split by product $0.00 | $0.00 |
| 2025-03-31 | Not split by product $0.00 | $0.00 |
| 2024-12-31 | Not split by product $4.00M 100.00% | $4.00M |
| 2024-09-30 | Not split by product $3.00M 100.00% | $3.00M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |